NUVAXOVID 2026-27

🇺🇸 United States

FDA Page

Effective Date: Aug 25, 2026
Approval ID: 9afb20dd-54ee-475a-98f3-5bfcf9546faf
Products: 0 registered
Version: 1

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NUVAXOVID safely and effectively. See full prescribing information for NUVAXOVID. NUVAXOVID™ (COVID-19 Vaccine, Adjuvanted) injectable suspension, for intramuscular use 2026-2027 Formula Initial U.S. Approval: 2025

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.